Nodular Melanoma
What's New
Last Posted: Nov 05, 2024
- BRAF and NRAS Mutations and the Association with Prognosis of Acral Lentiginous and Nodular Melanomas in Indonesia.
Sumadi Lukman Anwar, et al. Asian Pacific journal of cancer prevention : APJCP 2024 0 (10) 3525-3531 - Assessing the genetic risk of nodular melanoma using a candidate gene approach.
Mitchell S Stark, et al. The British journal of dermatology 2023 0 - Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG.
Anne Zaremba, et al. European journal of cancer (Oxford, England : 1990) 2023 0 140-151 - Sensitivity and Usefulness of VE1 Immunohistochemical Staining in Acral Melanomas with BRAF Mutation.
Suh Min Song, et al. Annals of dermatology 2021 0 (5) 556-561 - Two synchronous malignancies: nodular melanoma and renal cell carcinoma in a patient with an underlying germline BRCA2 mutation.
Snow Anson, et al. BMJ case reports 2019 0 (6) - Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient Cohort.
Chang Gregory A, et al. The Journal of investigative dermatology 2022 0 (10) 2733-2743.e9 - Different Response to Immunotherapy According to Melanoma Histologic Subtype.
Pala Laura, et al. Journal of immunotherapy (Hagerstown, Md. : 1997) 2021 0 (2) 119-124 - PD-L1 expression is regulated by microphthalmia-associated transcription factor (MITF) in nodular melanoma.
Vu?ini? Damir, et al. Pathology, research and practice 2021 0 153725 - BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients.
Dika Emi, et al. American journal of clinical pathology 2020 2 - Low BRAF V600 mutation prevalence in primary skin nodular melanoma in Indonesia: a real-time PCR detection among Javanese patients.
Rinonce Hanggoro Tri, et al. BMC proceedings 2019 0 (Suppl 11) 15
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: